Baird Financial Group Inc. Buys 15,389 Shares of DaVita Inc. (NYSE:DVA)

Posted by on Jun 11th, 2023

Baird Financial Group Inc. lifted its holdings in DaVita Inc. (NYSE:DVA – Get Rating) by 12.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 141,822 shares of the company’s stock after purchasing an additional 15,389 shares during the quarter. Baird Financial Group Inc. owned 0.16% of DaVita worth $10,589,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently modified their holdings of DVA. Sentry Investment Management LLC raised its stake in shares of DaVita by 63.4% in the fourth quarter. Sentry Investment Management LLC now owns 371 shares of the company’s stock worth $28,000 after purchasing an additional 144 shares during the last quarter. Eisler Capital UK Ltd. purchased a new position in shares of DaVita in the third quarter worth $35,000. Parkside Financial Bank & Trust raised its stake in shares of DaVita by 88.6% in the first quarter. Parkside Financial Bank & Trust now owns 313 shares of the company’s stock worth $35,000 after purchasing an additional 147 shares during the last quarter. Neo Ivy Capital Management purchased a new position in shares of DaVita in the third quarter worth $40,000. Finally, CoreCap Advisors LLC purchased a new position in shares of DaVita in the fourth quarter worth $107,000. Hedge funds and other institutional investors own 86.52% of the company’s stock.

Insider Transactions at DaVita

In other news, insider Kathleen Alyce Waters sold 15,941 shares of the company’s stock in a transaction dated Wednesday, May 10th. The stock was sold at an average price of $99.24, for a total value of $1,581,984.84. Following the completion of the transaction, the insider now owns 91,245 shares of the company’s stock, valued at $9,055,153.80. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In related news, CEO Javier Rodriguez sold 16,916 shares of the stock in a transaction that occurred on Wednesday, May 10th. The stock was sold at an average price of $99.44, for a total transaction of $1,682,127.04. Following the completion of the transaction, the chief executive officer now directly owns 315,622 shares of the company’s stock, valued at $31,385,451.68. The sale was disclosed in a filing with the SEC, which is available through this link. Also, insider Kathleen Alyce Waters sold 15,941 shares of the stock in a transaction that occurred on Wednesday, May 10th. The shares were sold at an average price of $99.24, for a total value of $1,581,984.84. Following the transaction, the insider now directly owns 91,245 shares of the company’s stock, valued at $9,055,153.80. The disclosure for this sale can be found here. Insiders sold a total of 37,502 shares of company stock valued at $3,722,146 over the last 90 days. Company insiders own 1.40% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts recently commented on DVA shares. Bank of America upped their price objective on DaVita from $86.00 to $96.00 in a research report on Tuesday, May 9th. TheStreet upgraded DaVita from a “c” rating to a “b-” rating in a research report on Monday, May 8th. Sanford C. Bernstein upped their price objective on DaVita from $88.00 to $100.00 in a research report on Monday, May 15th. Truist Financial upped their price objective on DaVita from $90.00 to $100.00 in a research report on Tuesday, May 9th. Finally, StockNews.com started coverage on DaVita in a research report on Thursday, May 18th. They set a “buy” rating for the company. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $96.88.

DaVita Stock Performance

NYSE DVA opened at $97.48 on Friday. The firm has a market cap of $8.84 billion, a price-to-earnings ratio of 17.99, a price-to-earnings-growth ratio of 1.00 and a beta of 0.93. The company has a quick ratio of 1.14, a current ratio of 1.18 and a debt-to-equity ratio of 8.25. The business has a 50-day moving average price of $91.19 and a 200-day moving average price of $82.68. DaVita Inc. has a twelve month low of $65.28 and a twelve month high of $103.00.

DaVita (NYSE:DVA – Get Rating) last released its quarterly earnings data on Monday, May 8th. The company reported $1.58 earnings per share for the quarter, topping analysts’ consensus estimates of $1.08 by $0.50. The firm had revenue of $2.87 billion during the quarter, compared to analyst estimates of $2.84 billion. DaVita had a return on equity of 72.08% and a net margin of 4.40%. The business’s quarterly revenue was up 2.0% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.61 earnings per share. As a group, equities research analysts predict that DaVita Inc. will post 6.69 EPS for the current fiscal year.

DaVita Company Profile

(Get Rating)

DaVita, Inc engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure.

Featured Articles

Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita Inc. (NYSE:DVA – Get Rating).

Institutional Ownership by Quarter for DaVita (NYSE:DVA)

Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.com's FREE daily email newsletter.